An MDM2 degrader for treatment of acute leukemias-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An MDM2 degrader for treatment of acute leukemias

Published:2022-10-29 Issue:2 Volume:37 Page:370-378
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Marcellino Bridget K.,Yang Xiaobao,Ümit Kaniskan H.,Brady Claudia,Chen He,Chen Karie,Qiu Xing,Clementelli Cara,Herschbein Lauren^ORCID,Li Zhijun,Elghaity-Beckley Sebastian,Arandela Joann,Kelly Brianna,Hoffman Ronald^ORCID,Liu Jing,Xiong Yue,Jin Jian^ORCID,Shih Alan H.^ORCID

Funder

MPN Research Foundation

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01735-6.pdf

Reference34 articles.

1. Rucker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012;119:2114–21.

2. Marcellino BK, Hoffman R, Tripodi J, Lu M, Kosiorek H, Mascarenhas J, et al. Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53. Blood Adv. 2018;2:3581–9.

3. Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, et al. Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica. 2013;98:908–12.

4. Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci. 1999;55:96–107.

5. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. The human MDM-2 oncogene is overexpressed in leukemias. Blood. 1993;82:2617–23.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade;Annals of Hematology;2024-09-12

2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

3. An overview of PROTACs targeting MDM2 as a novel approach for cancer therapy;European Journal of Medicinal Chemistry;2024-06

4. PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives;MedComm;2024-06

5. p53/MDM2 signaling pathway in aging, senescence and tumorigenesis;Seminars in Cancer Biology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3